Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Mar;22(3):485-486.
doi: 10.1038/mt.2014.13.

From gut to brain: bioencapsulated therapeutic protein reduces amyloid load upon oral delivery

Affiliations
Comment

From gut to brain: bioencapsulated therapeutic protein reduces amyloid load upon oral delivery

Imre Mäger et al. Mol Ther. 2014 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Strategy for reducing amyloid plaques in the brain and retina upon oral administration of bioencapsulated CTB-MBP fusion protein. Cholera toxin B subunit (CTB) and myelin basic protein (MBP) fusion protein are expressed in chloroplasts to achieve their bioencapsulation. After lyophilization, the therapeutic compound is orally administered to triple-transgenic Alzheimer's disease (3×TgAD) mice. Following transmucosal uptake in gut and transcytosis across the blood–brain barrier (BBB) and blood–retinal barrier (BRB), MBP reduces amyloid plaques in the brain and retina.

Comment on

Similar articles

Cited by

References

    1. Kohli N, Westerveld DR, Ayache AC, Verma A, Shil P, Prasad T.et al. (2014Oral delivery of bioencapsulated proteins across blood–brain and blood–retinal barriers Mol Ther 22535–546. - PMC - PubMed
    1. Pardridge WM. Drug transport across the blood–brain barrier. J Cereb Blood Flow Metab. 2012;32:1959–1972. - PMC - PubMed
    1. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S., and, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341–345. - PubMed
    1. Meng Y, Sohar I, Sleat DE, Richardson JR, Reuhl KR, Jenkins RB.et al. (2014Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain Mol Ther 22547–553. - PMC - PubMed
    1. Kwon K-C, Verma D, Singh ND, Herzog R., and, Daniell H. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev. 2013;65:782–799. - PMC - PubMed

MeSH terms